{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 2985"}, "official-title": {"#tail": "\n\t", "#text": "To amend section 505 of the Federal Food, Drug, and\n\t\t  Cosmetic Act to provide incentives for the development of new combination\n\t\t  drugs."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130802", "#text": "August 2, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee\n\t\t\t on Energy and Commerce"}, "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Chaffetz", "@name-id": "C001076"}, "cosponsor": [{"#tail": ", and\n\t\t\t ", "#text": "Mr. Coble", "@name-id": "C000556"}, {"#tail": ") introduced the following\n\t\t\t bill; which was referred to the ", "#text": "Mr. Salmon", "@name-id": "S000018"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H509D1D5477BD416E8A4E2A79E5D023A0", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Combination Drug Development Incentive\n\t\t\t Act of 2013"}, "#tail": " .", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H5B00D10A136C41769C75F0F39B917617"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Applicability to\n\t\t\t combination drugs submitted under a new drug application"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Clause (ii) of section 505(c)(3)(E) of the Federal Food,\n\t\t\t Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(c)(3)(E)(ii)", "@value": "usc/21/355/c/3/E/ii"}, "@parsable-cite": "usc/21/355", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": "\n\t\t\t and inserting ", "#text": "(ii) If an application submitted under subsection (b) for a drug, no\n\t\t\t active ingredient (including any ester or salt of the active ingredient) of\n\t\t\t which has been approved in any other application under subsection (b),"}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t for a drug, and described in ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, {"#tail": " or ", "@entity-type": "act", "#text": "subclause (II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii/scl:II", "@proposed": "true"}, {"#tail": ",", "@entity-type": "act", "#text": "(III)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii/scl:III", "@proposed": "true"}], "#text": "(ii)(I) If an application submitted under "}], "#text": "by striking\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H9F1B903F8C8543BB9BEFF61F91C0C093", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by adding at the\n\t\t\t end the following:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "subclause": [{"@indent": "up3", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, "#text": "An application is described in this\n\t\t\t\tsubclause if no active ingredient (including any ester or salt of the active\n\t\t\t\tingredient) of the drug for which the application has been submitted has been\n\t\t\t\tapproved in any other application under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(II)"}, "#text": "\n              ", "@id": "H196DC27C5BBE4AAEA29B5DA0B248340F"}, {"@indent": "up3", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "An application is described in this\n\t\t\t\tsubclause if\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(III)"}, "item": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the application contains reports\n\t\t\t\tof new clinical investigations (other than bioavailability studies) essential\n\t\t\t\tto the approval of the application and conducted or sponsored by the\n\t\t\t\tapplicant;"}, "enum": {"#tail": "\n                ", "#text": "(aa)"}, "@id": "H895672BE99F14C348EC2CCD466C7826E", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the application is for a drug\n\t\t\t\twhich contains a combination of active ingredients; and"}, "enum": {"#tail": "\n                ", "#text": "(bb)"}, "@id": "HDD88328782884AB299FC3BF9892C2D6D", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, "#text": "no such combination of active\n\t\t\t\tingredients has been approved in any other application under "}, "enum": {"#tail": "\n                ", "#text": "(cc)"}, "@id": "H0CDAB82021F948F2A582732FAB7AB147", "#text": "\n                "}], "#text": "\n              ", "@id": "HD2244797CA1647E2820AA42652BAF010"}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "H9D35A29EF3D24BD18EF4B92CABEDF6AB"}, "#text": "\n          ", "@id": "H654934D51AAC4763845715E710F6E775"}], "#text": "\n        ", "@id": "HAA0045009ADA4DFE96A44732C27E52A1"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as\n\t\t\t designated by ", "@entity-type": "act", "#text": "Subclause\n\t\t\t (I) of section 505(c)(3)(E)(ii) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii/scl:I"}, {"#tail": ", is amended by striking ", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Combination Drug Development Incentive Act of 2013/s:2/ss:a/p:1", "@proposed": "true"}], "#text": "\n          ", "quote": [{"#tail": " and inserting ", "#text": "is approved\n\t\t\t after the date of the enactment of this clause"}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subclause (II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii/scl:II"}, {"#tail": "\n          ", "@entity-type": "act", "#text": "subclause (III)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii/scl:III"}], "#text": "is\n\t\t\t approved after January 1, 2014, in the case of an application described in\n\t\t\t "}]}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Applicability"}, "#text": "\n        ", "@id": "HC285AD9D404F4B1299587D89914D6C08"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "If"}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",\n\t\t\t if", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:ii"}, "#text": "Except as provided in "}], "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Clause (iii) of section 505(c)(3)(E) of the Federal\n\t\t\t Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:E/cl:iii"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(c)(3)(E)", "@value": "usc/21/355/c/3/E"}, "@parsable-cite": "usc/21/355", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Conforming\n\t\t\t amendment"}, "#text": "\n        ", "@id": "H92D26C88B56A4698882C909B7F97F752"}], "#text": "\n      ", "@id": "H292583663A714EDBB1687662F4DDC3D6"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Applicability to\n\t\t\t combination drugs submitted under an abbreviated new drug application"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " of ", "@entity-type": "act", "#text": "Clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:ii"}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 505(j)(5)(F) of the Federal Food,\n\t\t\t Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(j)(5)(F)", "@value": "usc/21/355/j/5/F"}, "@parsable-cite": "usc/21/355", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": "\n\t\t\t and inserting ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a drug, no\n\t\t\t active ingredient (including any ester or salt of the active ingredient) of\n\t\t\t which has been approved in any other application under ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, {"#tail": ",", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}], "#text": "(ii) If an application submitted under "}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t for a drug, and described in ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, {"#tail": " or ", "@entity-type": "act", "#text": "subclause (II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:ii/scl:II", "@proposed": "true"}, {"#tail": ",", "@entity-type": "act", "#text": "(III)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:ii/scl:III", "@proposed": "true"}], "#text": "(ii)(I) If an application submitted under "}], "#text": "by striking\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HD6B7FEF1CF9A48009511170963A25741", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by adding at the\n\t\t\t end the following:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "subclause": [{"@indent": "up4", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, "#text": "An application is described in this\n\t\t\t\tsubclause if no active ingredient (including any ester or salt of the active\n\t\t\t\tingredient) of the drug for which the application has been submitted has been\n\t\t\t\tapproved in any other application under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(II)"}, "#text": "\n              ", "@id": "HDB17DFE8BC3F4B2B9E99476EF64B687F"}, {"@indent": "up4", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "An application is described in this\n\t\t\t\tsubclause if\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(III)"}, "item": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the application contains reports of\n\t\t\t\tnew clinical investigations (other than bioavailability studies) essential to\n\t\t\t\tthe approval of the application and conducted or sponsored by the\n\t\t\t\tapplicant;"}, "enum": {"#tail": "\n                ", "#text": "(aa)"}, "@id": "H697A95823E3B4269AA30F5C3D814C4DC", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the application is for a drug which\n\t\t\t\tcontains a combination of active ingredients; and"}, "enum": {"#tail": "\n                ", "#text": "(bb)"}, "@id": "H45EAAF17113142238CE00DF7E336201E", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, "#text": "no such combination of active\n\t\t\t\tingredients has been approved in any other application under "}, "enum": {"#tail": "\n                ", "#text": "(cc)"}, "@id": "H364346FAB83D4DEFBFC98A105C490801", "#text": "\n                "}], "#text": "\n              ", "@id": "HFC09C4C3234A46EEA8FCE64C2419EC14"}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "HEE12537B56EF4F6B8DC3DC3097B7323C"}, "#text": "\n          ", "@id": "H4FA49DB8BFEC45C781227D6E2E0783B0"}], "#text": "\n        ", "@id": "HF77508356AF043FE9A1B973F9BDF9554"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as designated by ", "@entity-type": "act", "#text": "Subclause (I) of section 505(j)(5)(F) of\n\t\t\t the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:ii/scl:I"}, {"#tail": ",\n\t\t\t is amended by striking ", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Combination Drug Development Incentive Act of 2013/s:3/ss:a/p:1", "@proposed": "true"}], "quote": [{"#tail": " and inserting ", "#text": "is approved after the date of the enactment of\n\t\t\t this subsection"}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subclause (II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/scl:II", "@proposed": "true"}, {"#tail": "\n          ", "@entity-type": "act", "#text": "subclause\n\t\t\t (III)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/scl:III", "@proposed": "true"}], "#text": "is approved after January 1, 2014,\n\t\t\t in the case of an application described in "}], "#text": "\n          ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Applicability"}, "#text": "\n        ", "@id": "H400A3A0A471C49ABA3BC25B5CD00FC77"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " of ", "@entity-type": "act", "#text": "Clause (iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:iii"}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 505(j)(5)(F) of the Federal\n\t\t\t Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(j)(5)(F)", "@value": "usc/21/355/j/5/F"}, "@parsable-cite": "usc/21/355", "#text": "\n              ", "@legal-doc": "usc"}}, "quote": [{"#tail": " and inserting ", "#text": "If"}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",\n\t\t\t if", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F/cl:ii"}, "#text": "Except as provided in "}]}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Conforming\n\t\t\t amendment"}, "#text": "\n        ", "@id": "HBFE929987CD54DCA994F66948E42A54A"}], "#text": "\n      ", "@id": "H7AA86C57C8A14A50B46101D47FE8D2C1"}], "#text": "\n\t\t", "@id": "HD9F3F953D81540D68A0ED44FBD69B9C9"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-08-02"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 2985 IH: Combination Drug Development Incentive Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}